Aura Biosciences Inc (AURA)
US$ 7.560.8%
Price Chart
Key Statistics
Market Cap
$ 297.59M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
125.85K
52W High
$ 12.38
52W Low
$ 4.34
Dividend Yield
0.00%
Beta
0.43
Technicals
50-Day MA
6.0036
200-Day MA
8.009
52 Week High
12.3782
52 Week Low
4.345
About AURA
Aura Biosciences, Inc., a clinical-stage biotechnology company, develops precision immunotherapies to treat a range of solid tumors.
Employees
106
Headquarters
Boston, MA
CEO
Dr. Elisabet de los Pinos Ph.D.
Latest News
Xreal and Google Debut Aura AR Glasses to Rival Meta’s Orion Plan - Bloomberg.com
4 hours ago • Google News
Xreal Unveils Project Aura, New AI-Powered Android XR Glasses, at Google I/O - CNET
3 hours ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg